AVEO Oncology doses first patient in pioneering AML clinical trial
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
The move strengthens GBL’s clinical-stage presence in the United States
Subscribe To Our Newsletter & Stay Updated